AgelessRx vs Noom
Microdosing — using a lower-than-standard GLP-1 dose to seek moderate weight loss with fewer side effects — has become a distinct product category, and these are two of its most visible offerings. They come at it from opposite directions: AgelessRx from longevity medicine, Noom from behaviour change.
Last updated August 5, 2026
Side by side
| Dimension | AgelessRx | Noom |
|---|---|---|
| Microdosing entry price | Microdosing semaglutide from $99/month; tirzepatide from $159/month | Microdose GLP-1 program offered alongside standard dosing |
| Standard-dose option | Injectable GLP-1 treatments from $139/month | Standard GLP-1 program available |
| Published eligibility criteria | BMI under 25 not eligible; 25-29.9 case-by-case; 30+ likely | Not published in the same detail |
| Brand-name access | Wegovy pill from $199/mo; Wegovy and Zepbound monitoring plans | Branded telehealth tier available |
| Behaviour-change program | Longevity and healthspan framing rather than structured coaching | Core strength — established behaviour-change curriculum |
| Clinical model | In-house US-licensed medical providers | Clinician network with app-led program |
| HSA/FSA | Accepted | Not stated in the same terms |
| Cancellation | Pause or cancel anytime | Subscription-based |
Highlighted cells indicate the stronger position on that dimension only. Facts are taken from each provider's own published materials and are recorded in full on their individual review pages.
Choose AgelessRx if…
- You want microdosing as a deliberate clinical strategy within a longevity framework
- You want published BMI eligibility guidance before you engage
- You are already on brand-name medication and want a monitoring plan
- You want to pause or cancel without friction
Choose Noom if…
- You want structured behaviour change alongside medication
- You want an established consumer app experience and community
- You have used Noom before and want to add a medication tier
- You value curriculum and habit tracking as much as the prescription
Our verdict
AgelessRx is the stronger clinical proposition for microdosing specifically: published BMI thresholds that explicitly exclude people, in-house licensed providers, transparent pause-and-cancel terms, and a longevity framing that is honest about targeting moderate rather than maximal weight loss. Noom's advantage is everything around the medication — a mature behaviour-change program that addresses the part of weight management a prescription cannot. Be clear-eyed on both: microdosing is not an FDA-approved dosing strategy, and the outcome data behind semaglutide and tirzepatide comes from standard titration to therapeutic doses.
Frequently asked questions
Does GLP-1 microdosing actually work?
The honest answer is that the evidence base is thin. The large trials behind semaglutide and tirzepatide used standard titration to full therapeutic doses. Microdosing is a clinical strategy some providers offer to reduce side effects and cost, and patients do report moderate weight loss, but it is not an FDA-approved dosing approach and you should not expect trial-level results. Discuss realistic expectations with your clinician.
Is microdosing cheaper?
Usually, yes — AgelessRx starts microdosing semaglutide at $99/month against $139/month for its standard injectable treatments. Lower doses use less active ingredient. Whether it is better value depends entirely on whether the smaller dose produces a result you consider worthwhile.
Compare more options
Medical disclaimer
This comparison is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Pricing, medication availability, pharmacy partners and policies change frequently and vary by state — verify everything directly with the provider before purchasing.